Compliance

Focus Area Working Group

The goals of the Medical Affairs Professional Society Compliance Focus Area Working Group are to create a community that advances our role as fully integrated strategic business partners to promote the growth of Compliance and Medical Affairs Professionals within the life sciences sector worldwide; to develop our Compliance community within MAPS to become the premier global destination of choice for Compliance and related Medical Affairs Professionals, noting the synergies and close working relationships across the teams; and to catalyze our individual personal leadership development and professional career advancement. ​ 

Activities: We will organize Compliance-related workshops for MAPS meetings in the North America, APAC (Asia Pacific – China/Japan), and EMEA (Europe, Middle East, Asia) regions. We develop original content for webinars, podcasts, eLearning courses and white papers. In addition, the working group will periodically contribute cogent and timely content on the Compliance sector for the MAPS publication, Elevate magazine. Most importantly, we will provide a supportive resource for all Compliance and related Medical Affairs Professionals. ​ 

Members

Jennie Orrico

Jennie Orrico

Global Chief Compliance and Risk Executive

Lead

GE Healthcare Logo
Maureen Lloyd

Maureen Lloyd

Executive Director

LloydMJMC Inc

Kendi Miaro

Kendi Miaro

Head, Ethics and Business Integrity, ESA and Nigeria-Ghana
Sanofi Logo
Jessica Santos

Jessica Santos

Global Compliance and Quality Director, Health Division
Kantar Logo
Jenny McVey

Jenny McVey

Compliance Risk Strategy and Mitigation Ethics and Compliance
Novo Nordisk Logo
Erinn Hutchinson

Erinn Hutchinson

Principal, Pharmaceutical and Life Sciences Advisory Group
PwC Logo
Ann Ford

Ann Ford

Partner/Managing Director HPS Advise, Hall
Prangle & Schoonveld
Bill Hrubes

Bill Hrubes

Chief Compliance Officer
ACell Logo
Tara D’Orsi

Tara D’Orsi

EVP General Counsel & Chief Compliance Officer
Kyowa Kirin Logo
William Mwiti

William Mwiti

Director, Quality and Risk, Global Safety and Medical Governance
GSK Logo
Tina Beamon

Tina Beamon

Vice President, Chief Compliance Officer
Margaret Price

Margaret Price

Ethics and Compliance Officer, Medical Devices

FAWG Overview

Compliance Updates

, , , , , , , , ,

Make Communications, Not War: Best Practices for Medical, Legal and Regulatory Review

This MAPS webinar details potential hurdles of the MLR review process​, function alignment, and our changing MLR environment and possible solutions.
, , , , , , , , , ,

Enforcement and Compliance ​ in Current Times

This MAPS webinar details enforcement trends, key risks associated with the shift from in-person to virtual activities due to the pandemic and compliance considerations for conducting promotional and educational activities virtually.
Pandemic Silver Lining Featured
EU.MedTech.ELEVATE.Featured
, , , , , , , ,

A Compelling Strategic Role for Medical Affairs in the Context of the new EU MedTech Regulations

This article provides an overview of the new MedTech European regulatory environment and opportunities for the Medical Affairs function to evolve and bring value to the respective organizations.
20
, , , ,

Impact of COVID-19 on Global MA Compliance Panel

Join expert panelists on this Webinar to better understand compliance implications of the changing business models during and post-COVID, and identify Medical Affairs compliance risks and mitigation strategies.
60
, , ,

Medical Affairs Excellence and Ethics & Compliance in the Evolving Healthcare Landscape – Collaborating and Leading by Example

This Webinar explores: the role of Medical Affairs in guiding ethical decisions internally and externally; the impact of Medical Affairs beyond its remit; the importance of sharing best practices for the role of Medical Affairs in strategic brand planning, and the ethics and compliance considerations for Medical Affairs plans.
42
, , ,

Compliance Considerations in Medical/Commercial Collaborations

In this webinar, we explore two scenarios that can open Medical Affairs up to censure. Scenario one explores participation of commercial team members in Medical Advisory Boards and scenario two looks at the implications of a commercial team member requesting a medical team member to participate in a thought leader meeting.